Showing results (11-20 of 240) with videos related to
Sort By:
Pageof 24
Cell Chemical Biology|September 17, 2021
Hypoxia-activated KDAC inhibitor: Taking a breath from untargeted therapyMaximilian Staudt, Manfred JungArchiv Der Pharmazie|July 26, 2005
Chromatin modifications as targets for new anticancer drugsStefan Schäfer, Manfred JungPlanta Medica|August 16, 2008
Targeting epigenetic mechanisms: potential of natural products in cancer chemopreventionAlexander-Thomas Hauser, Manfred JungChemistry & Biology|July 28, 2010
No taste for methyl: methylation sensitive proteolysis in drug screeningElisabeth-Maria Bissinger, Manfred JungThe International Journal of Biochemistry & Cell Biology|September 9, 2008
Cancer treatment of the future: inhibitors of histone methyltransferasesAstrid Spannhoff, Wolfgang Sippl, Manfred JungCancer Letters|March 10, 2009
Histone deacetylase inhibitors that target tubulinJörg Schemies, Wolfgang Sippl, Manfred JungBlood|August 16, 2003
Induction of human gamma globin gene expression by histone deacetylase inhibitorsHua Cao, George Stamatoyannopoulos, Manfred JungClinical Epigenetics|May 26, 2016
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapyLudovica Morera, Michael Lübbert, Manfred JungExperimental Hematology|December 13, 2005
Hydroxamide derivatives of short-chain fatty acid have erythropoietic activity and induce gamma gene expression in vivoHua Cao, Manfred Jung, George StamatoyannopoulosCancer Research|April 19, 2006
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymesBirgit Heltweg, Tonibelle Gatbonton, Aaron D Schuler, et al.Pageof 24